The WATER study clinical results - a phase III blinded randomized trial of aquablation vs. TURP with blinded outcome assessment for moderate-to-severe LUTS in men with BPH
BAUS ePoster online library. Barber N. 06/27/18; 211368; P8-7 Disclosure(s)(s): Honorariums and educational support from Olympus, Neotract, Procept-Biorobotics, Intuitive Surgical
Mr. Neil Barber
Mr. Neil Barber
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Rate & Comment (0)
Introduction: Early reports of Aquablation for lower urinary tract symptoms due to benign prostatic hyperplasia suggest efficacy similar to that of TURP. We aimed to compare the safety and efficacy vs TURP (T).

Methods: In this randomized, blinded, multi-centre phase III trial, men with moderate to severe LUTS related to BPH were assigned to TURP or Aquablation. Six month outcomes are reported for critical safety and efficacy endpoints.

Results: The mean baseline IPSS score, demographic profile (Table 1), and mean prostate volume were similar in both arms.
In the Aquablation group at 6 months, 26% had a safety endpoint event; in the TURP group, 43% had an event. The difference was -17% thus demonstrating superiority of Aquablation versus TURP. For sexually active men, the anejaculation rates for TURP, Aquablation with cautery, and Aquablation without cautery were 38%, 16%, and 7%, respectively.
Mean IPSS scores decreased from 22.9 at baseline to 5.9 at 6 months in the Aquablation group and from 22.2 at baseline to 6.8 in the TURP group demonstrating non-inferiority. Men with prostate size >50 mL had superior improvements in IPSS after Aquablation compared to TURP (p=.0099).

Conclusions: In patients with LUTS due to BPH, surgical prostate resection using a robotically guided waterjet showed non-inferior symptom relief compared to TURP but with a lower risk of sexual dysfunction. This new semi-automated approach may diminish the need for substantial surgical experience to achieve optimal results.

    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings